Korea’s aesthetic medicine enjoys golden era with surge in foreign spending
As beauty-conscious tourists continue to flock to Seoul’s clinics, South Korea’s aesthetic medicine sector may be entering a golden era,...
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Samsung lowers bar on hiring foreign talent in South Korea
South Korea’s biggest business group Samsung has sweetened the pot to win the technology talent war by lowering the bar for new hires of forei...
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...
Korea’s booming medical tourism: Skin care, plastic surgery in demand
The number of foreign patients visiting South Korea for medical tourism hit a record high last year, driven by those who traveled to Korea for skin ...
Mathpresso throws down the gauntlet in US edtech market
Mathpresso Inc., a South Korean startup operating the Google-backed learning app Qanda, has released its first study app catering to US university s...
Daewoong gets stem cell facility license in Indonesia
South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational...
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Samsung Bioepis gets FDA OK for its interchangeable biosimilar
Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Daewoong Pharma's GER drug gets product OK from Mexico
South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...
Gluten-free Korean snack, pea soy sauce lure European gourmets
COLOGNE, Germany – The traditional Korean snack yakgwa and a soy-like sauce made with peas were named innovative foods of the year at the worl...
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Moderna signs mRNA access deals with S.Korea's universities
The US biotech and pharmaceutical company Moderna on Friday announced signings of contracts with the academic-industry cooperation foundations of Ko...
Celltrion’s Vegzelma listed on prescription of 10 private US insurers
South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...
KT to hold AI coding lectures at universities
South Korea’s KT Corp. is expanding operations of its artificial intelligence (AI) coding education platform AI Codiny.The company on Sunday s...
SK Bioscience buys 6.5 million Novavax shares for $83.4 million
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...
CJ Logistics to enter global pharmaceutical transportation market
South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...
LG Uplus to open metaverse for Yonsei Univ. in September
South Korea's LG Uplus Corp. on Wednesday announced the opening in September of Virtual Campus, a metaverse for Yonsei University, one of the nation...
SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada
South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...
Blackstone seeks medicine distributor sale for 1st Korea exit
Blackstone Inc. has embarked on the process of selling South Korea’s largest medicine wholesaler Geo-Young Corp., a deal estimated at up to $1...
Samsung Biologics wins $897 mn in two deals with Pfizer
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Hyundai Motor, Vietnam Nat'l Univ., Hanoi promote HR development
Hyundai Motor Group Chairman Chung Eui-sun is rolling up his sleeves to develop human resources in Vietnam. Accompanying the economic delegation of ...
S.Korea's Osteonic starts sports medicine exports to Japan
South Korea's surgical and medical instruments maker Osteonic Co. on Thursday announced the start of exports of its Kinex sports medicine products t...
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey
South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...
S.Korea's Celltrion Healthcare launches Vegzelma in US
South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...
Kobiolabs, Kakao Healthcare to explore microbiome-based precision medicine solutions
Kobiolabs Co., South Korea's new drug development company for microbiomes, announced on Tuesday that it has signed a memorandum of understanding for...
